6.
Seth A, Kong I, Lee S, Yang J, Lee Y, Kim Y
. Modular virus-like particles for sublingual vaccination against group A streptococcus. Vaccine. 2016; 34(51):6472-6480.
DOI: 10.1016/j.vaccine.2016.11.008.
View
7.
Walkinshaw D, Wright M, Mullin A, Excler J, Kim J, Steer A
. The Streptococcus pyogenes vaccine landscape. NPJ Vaccines. 2023; 8(1):16.
PMC: 9925938.
DOI: 10.1038/s41541-023-00609-x.
View
8.
Loh J, Lorenz N, Tsai C, Khemlani A, Proft T
. Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses. Sci Rep. 2017; 7(1):7174.
PMC: 5543120.
DOI: 10.1038/s41598-017-07602-0.
View
9.
Ozberk V, Reynolds S, Huo Y, Calcutt A, Eskandari S, Dooley J
. Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from Mutant Streptococcus pyogenes. mBio. 2021; 12(1).
PMC: 8545125.
DOI: 10.1128/mBio.03537-20.
View
10.
Watkins D, Johnson C, Colquhoun S, Karthikeyan G, Beaton A, Bukhman G
. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med. 2017; 377(8):713-722.
DOI: 10.1056/NEJMoa1603693.
View
11.
Yousif M, Felek A, Saydam M, Wilson S, Murdan S, Mawas F
. Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells. Vaccine. 2022; 40(42):6055-6063.
DOI: 10.1016/j.vaccine.2022.08.064.
View
12.
Christensen D, Mortensen R, Rosenkrands I, Dietrich J, Andersen P
. Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses. Mucosal Immunol. 2016; 10(1):260-270.
DOI: 10.1038/mi.2016.28.
View
13.
Araujo Correa V, Portilho A, De Gaspari E
. Vaccines, adjuvants and key factors for mucosal immune response. Immunology. 2022; 167(2):124-138.
DOI: 10.1111/imm.13526.
View
14.
Dassel J, Ralph A, Carapetis J
. Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?. Curr Opin Pediatr. 2014; 27(1):116-23.
DOI: 10.1097/MOP.0000000000000164.
View
15.
Bennett J, Rentta N, Leung W, Atkinson J, Wilson N, Webb R
. Early diagnosis of acute rheumatic fever and rheumatic heart disease as part of a secondary prevention strategy: Narrative review. J Paediatr Child Health. 2021; 57(9):1385-1390.
DOI: 10.1111/jpc.15664.
View
16.
Yokoyama Y, Harabuchi Y
. Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice. Int J Pediatr Otorhinolaryngol. 2002; 63(3):235-41.
DOI: 10.1016/s0165-5876(02)00021-6.
View
17.
Bessen D, Fischetti V
. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med. 1988; 167(6):1945-50.
PMC: 2189674.
DOI: 10.1084/jem.167.6.1945.
View
18.
Paris A, Colomb E, Verrier B, Anjuere F, Monge C
. Sublingual vaccination and delivery systems. J Control Release. 2021; 332:553-562.
DOI: 10.1016/j.jconrel.2021.03.017.
View
19.
Turner C, Kurupati P, Wiles S, Edwards R, Sriskandan S
. Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine. 2009; 27(36):4923-9.
PMC: 2759039.
DOI: 10.1016/j.vaccine.2009.06.042.
View
20.
Shaw H, Ozanne J, Burns K, Mawas F
. Multicomponent Vaccines against Group A Streptococcus Can Effectively Target Broad Disease Presentations. Vaccines (Basel). 2021; 9(9).
PMC: 8473114.
DOI: 10.3390/vaccines9091025.
View